Current sort has key articles at the top. Click on "Article Date" to sort by date, click on specific "tag" to view all articles in that category.
Title | |
---|---|
Association of Mental Health Burden With Prenatal Cannabis Exposure From Childhood to Early Adolescence: Longitudinal Findings From the Adolescent Brain Cognitive Development (ABCD) Study 12/01/2022 |
Conclusions and relevance: This study suggests that prenatal cannabis exposure and its correlated factors are associated with greater risk for psychopathology during middle childhood. Cannabis use during pregnancy should be discouraged. prenatal, Pregnancy, mental health, study, Research, 2023 Presentation Dr Berry |
Sperm DNA methylation alterations from cannabis extract exposure are evident in offspring 11/20/2022 |
Conclusions: This is the first characterization of the effect of cannabis exposure on the entirety of the rat sperm methylome. We identified CE-associated methylation changes across the sperm methylome, some of which persisted despite a "washout" period. Select methylation changes validated via bisulfite pyrosequencing, and genes associated with methylation changes were involved in early developmental processes. Preconception CE exposure is associated with detectable changes in offspring DNA methylation that are functionally related to changes in gene expression and cardiomegaly. These results support that paternal preconception exposure to cannabis can influence offspring outcomes. study, Research, rats, offspring, heredity, 2023 Presentation Dr Berry |
Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain 11/16/2022 |
Findings This meta-analysis of 20 studies of 1459 individuals found a significant pain reduction in response to placebo in cannabinoid randomized clinical trials. Media attention was proportionally high, with a strong positive bias, yet not associated with the clinical outcomes. Placebo, meta-analysis, JAMA, 2023 Presentation Dr Berry, study, Research |
The Pharming of Cannabis: Have We Not Learned the Lesson from the Overuse of Opioids? 11/14/2022 |
opioid, 2023 Presentation Dr Berry |
Marijuana Legalization and Opioid Deaths 02/16/2022 |
These results indicate that legal medical marijuana, particularly when available through retail dispensaries, is associated with higher opioid mortality. The results for recreational marijuana, while less reliable, also suggest that retail sales through dispensaries are associated with greater death rates relative to the counterfactual of no legal cannabis. fatal, opioid, Fatalities, Medical, 2023 Presentation Dr Berry |
How Weed Became the New OxyContin 01/16/2022 |
“I started seeing people with the worst psychosis symptoms that I have ever seen,” she told me. “And the worst delusions I have ever seen.” These cases were even more acute than what she’d seen from psychotic patients on meth. Some of the delusions were accompanied by “severe violence.” But these patients were coming up positive only for cannabis. They’re made by putting pulverized marijuana into a tube and running butane, propane, ethanol, or carbon dioxide through it, which separates the THC from the rest of the plant. The end product is a wax that can be 70% to 80% THC. That wax can then be put in a vacuum oven and further concentrated into oils that are as much as 95% or even 99% THC. Known as “dabs,” this is what people put in their vape pens, and in states like California and Colorado it’s totally legal and easily available to children. “There are no caps on potency,” said Stack. Stack, opioids, 2023 Presentation Dr Berry |
Intensity of cannabis use: Findings from three online surveys 01/17/2020 |
Findings: Respondents who reported using daily (i.e., 30 days in the past month) consumed almost twice as much per day of use on average as did those reporting less than daily. We find only modest increases in intensity among those using less than daily, but then a substantial increase (p< 0.001) for those who use daily. Most respondents report that on heavy or light use days their consumption differs from a typical day of use by a factor of 2 or more, but only about 25% of days were described as heavy or light. We estimate those using cannabis 21+ days a month account for 80% of consumption vs. 71% of the days of use. Caulkins, 2023 Presentation Dr Berry |
Statistics on Cannabis Users Skew Perceptions of Cannabis Use 01/17/2013 |
In summary, by sampling on use-days and amount used, we find that most of the consumption and, hence, most of the associated intoxication and flow of money into the black markets, comes from people who use frequently. Examining the number of users can be enlightening but does not fully capture the dynamics of cannabis usage. In order to understand market-related quantities like demand, and to better assess implications for crime, health, and productivity, researchers should analyze cannabis usage indicators like use-days and quantity consumed. marijuana use, 2023 Presentation Dr Berry |
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood 02/16/2010 |
Conclusions and Relevance Although individual-level risk remains moderate to low and results from this study should be confirmed in future adequately powered prospective studies, the high prevalence of adolescents consuming cannabis generates a large number of young people who could develop depression and suicidality attributable to cannabis. This is an important public health problem and concern, which should be properly addressed by health care policy. anxiety, depression, suicide, study, meta-analysis, Research, 2023 Presentation Dr Berry |